Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 8,552 shares at $16.45 ($141K) on 2025-05-02, disclosed to the SEC on 2025-05-07.
Open-market sale of $141k EWTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.45 | 4,276 | $70K | 50.0% |
| 2 | $16.45 | 4,276 | $70K | 50.0% |
| Total | $16.45 avg | 8,552 | $141K | 100% |
| Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |
| EWTX | SELL | 2024-05-03 | $119K | — | Filing → |